Members' publications (the 5 most prominent ones and those from 2007) will be mentioned here

Dr. P. Deltenre
DELTENRE P. et al. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis, Gut, 1999, 44, pp. 886-8
DELTENRE P. et al. Factor V Leiden-related Budd-Chiari syndrome, Gut, 2001, 48, pp. 264-8
DELTENRE P. et al. Lack of prognostic usefulness of hepatic venous pressure and hemodynamic values in a select group of patients with severe alcoholic cirrhosis, Am J Gastroenterol, 2002, 97, pp. 1187-90
DELTENRE P. et al. Evaluation of amantadine in chronic hepatitis C: a meta-analysis, J Hepatol, 2004, 41, pp. 462-73
DELTENRE P. et al. Ischemic cholangiopathy, J Hepatol, 2006, 44, pp. 806-17
DELTENRE P. et al. Ischemic cholangiopathy, J Hepatol, 2006, 44, pp. 806-17
DELTENRE P. et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites, Gastroenterology, 2006, 130, pp. 1372-3
LOUVET A. , NAVEAU S,, DELTENRE P., et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids, Hepatology, 2007, 45, pp. 1348-54
LOUVET A. , DIAZ E., DELTENRE P., et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids, J Hepatol, 2008, 48, pp. 465-70

Pr. J. Delwaide
DELWAIDE J. , BOURGEOIS N, GERARD C, et al. Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response., Aliment Pharmacol Ther, 2004, 20, pp. 15-22
GERARD C , DELWAIDE J, VAIRA D, et al. Evolution over a 10-year period of the epidemiological profile of 1726 newly diagnosed HCV patients in Belgium., J Med Virol, 2005, 76, pp. 503-510
DELWAIDE J. , EL SAOUDA R, GERARD C, et al. Hepatitis C infection: eligibility for antiviral therapies., Eur J Gastroenterol Hepatol, 2005, 17, pp. 1185-1189
DELWAIDE J. , REENAERS C, GERARD C, et al. HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin., Eur J Gastroenterol Hepatol, 2006, 18, pp. 707-712
DELWAIDE J. , GERARD C, REENAERS C, et al. Hepatitis C virus genotype 5 in Southern Belgium: epidemiological characteristics and response to therapy., Dig Dis Sci, 2005, 50, pp. 2348-2351
DELWAIDE J. , Economic evaluation of chronic hepatitis C treatment by interferon-ribavirin combination therapy in Belgium., Acta Gastroenterol Belg, 2002, 65, pp. 233-236
DELWAIDE J. , Postexposure management of hepatitis A, B, or C: treatment, postexposure prophylaxis and recommendations., Acta Gastroenterol Belg, 2003, 66, pp. 250-253
BUSTER E , HANSSEN B, BUTI M, DELWAIDE J, NIEDERAU C, MICHIELSEN P, FLISIAK R, ZONDERVAN P, SCHALM S, JANSSEN H Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis., Hepatology, 2007, 46, pp. 388-394
DETRY O , DE ROOVER A, COIMBRA C, DELWAIDE J, HANS MF, DELBOUILLE M, MONARD J, JORIS J, DAMAS P, BELAICHE J, MEURISSE M, HONORE P Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: a 20-year experience., World J Gastroenterol, 2007, 13, pp. 1427-1430
LANGLET P , DELWAIDE J, , Comment interpréter une élévation de la ferritine sérique?, Rev Med Brux, 2007, 28, pp. 265-269
DETRY O , DE ROOVER A, COIMBRA C, DETROZ B, DELWAIDE J, KABA A, POLUS M, LAMPROYE A, JORIS J, BELAICHE J, MEURISSE M, HONORE P Recent advances in liver surgery and transplantation., Rev Med Liège, 2007, 62, pp. 310-316
BELAICHE J. , DELWAIDE J, POLUS M, LOUIS E Therapeutic updatein gastroenterology., Rev Med Liège, 2007, 62, pp. 303-309
COLLE I , ADLER M, BRENARD R, HENRION J, LANGLET P, MICHIELSEN P, ORLENT H, REYNAERT H, SPRENGERS D, STARKEL P, VAN DAMME P, VERSLYPE C, DELWAIDE J Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines., Acta Gastroenterol Belg, 2007, 7, pp. 389-420
DELWAIDE J. , Treatment of chronic hepatitis B in the era of antiviral therapies: what is the place of peginterferon in first line therapy?, Interface, 2007, 26, pp. 39541
LAMPROYE A , BELAICHE J, DELWAIDE J, Le fibroscan: une nouvelle méthode d'évaluation non invasive de la fibrose hépatique., Rev Med Liège, 2007, 62, pp. 68-72
DETRY O , DE ROOVER A, DELWAIDE J, HANS MF, CANIVET J, MEURISSE M, HONORE P. Prolonged anhepatic state after early graft removal., Hepato-Gastroenterology, 2007, 54, pp. 2109-2112
DELWAIDE J. , Hépatites C et B: attitude en cas de risque de contamination, traitement des formes aiguës et chroniques., Traité de Médecine Hospitalière., 2007, , pp. 678-681

Pr. P. Deprez
DEPREZ P.H. , GOSH P.H., GOODLAD R.A., et al. Hypergastrinemia: a new mechanism, Lancet, 1991, 338, pp. 410-411
DEPREZ P.H. , FIASSE R., , et al. Healing of severe oesophagitis improves esophageal motor dysfunction, Dig Dis Sci, 1999, 44, pp. 125-133
BATAILLE L. , DEPREZ P.H., , A new application for therapeutic EUS: main pancreatic duct drainage with a « pancreatic rendezvous technique, Gastrointest Endosc, 2002, 55, pp. 740-743
DEPREZ P.H. , SEMPOUX Ch., VAN BEERS B.E., et al. Persistent decreased plasma cholecystokinin levels in celiac patients under gluten free diet: respective roles of histological changes and nutrient hydrolysis, Regul Pept, 2002, 110, pp. 55-63
BORBATH I. , VAN BEERS B.E., LONNEUX M., et al. Preoperative assessment of pancreatic tumors using magnetic resonance imaging, endoscopic ultrasonography, positron emission tomography and laparoscopy, Pancreatology., 2005, 0, pp. 553-61
DEPREZ P.H. , AOUATTAH T., PIESSEVAUX H., et al. Endoscopic removal or ablation of oesophageal and gastric superficial tumours, Acta Gastroenterol Belg, 2006, 69, pp. 304-311
WEYNAND B. , BORBATH I., DEPREZ P.H., et al. Punctures with digestive echo-endoscopy, Ann Pathol., 2006, 1, pp. 82-4
BENYOUNES M. , DEPREZ P.H., , et al. A single therapeutic echo endoscope used for combined transgastric and transpapillary drainage of a pancreatic abscess, Endoscopy., 2006, 38, pp. 98
DEPREZ P.H. , The role of endoscopic ultrasound in biliary lithiasis, Acta Endoscopica, 2007, 37, pp. 617
STAINIER L. , HUBERT C., DEPREZ P.H., et al. Self-expanding metallic stents in benign postoperative biliary strictures: a difficult surgical obstacle?, Hepatogastroenterology., 2007, 0, pp. 999-1003
GOHY S. , HUBERT C., DEPREZ P.H., et al. Benign biliary inflammatory pseudotumor mimicking a Klatskin tumor., Hepatogastroenetrology, 2007, 54, pp. 1348-1352
ANTAKI F , TRINGALI A, DEPREZ P, et al. A case series of symptomatic intraluminal duodenal duplication cysts: presentation, endoscopic therapy, and long-term outcome (with video)., Gastrointest Endoscopy, 2008, 67, pp. 163-168

Dr. O. Detry
DETRY O , DEROOVER A, DELWAIDE J, et al. Prolonged anhepatic state after early liver graft removal, Hepatogastroenterology, 2007, 54, pp. 2109-2112
DETRY O. , DE ROOVER A., HONORE P, Prevention and treatment of major blood loss, N Engl J Med, 2007, 357, pp. 1261
DETRY O. , DE ROOVER A., COIMBRA C., et al. Recent advances in liver surgery and transplantation, Rev Med Liège, 2007, 62, pp. 310-316
DETRY O. , DE ROOVER A., COIMBRA C., et al. Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: a 20-year experience, World J Gastroenterol, 2007, 13, pp. 1427-1430
DETRY O. , DE ROOVER A., HONORE P., et al. Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management, World J Gastroenterol, 2006, 12, pp. 7405-7412
DETRY O. , DE ROOVER A., DELWAIDE J, et al. Liver transplantation in Jehovah's witnesses, Transpl Int, 2005, 18, pp. 929-936
DETRY O. , DE ROOVER , DELWAIDE J, et al. Living related liver transplantation in adults: first year experience at the University of Liege, Acta Chir Belg, 2004, 104, pp. 166-171
DETRY O. , HONORE P, HANS MF, et al. Organ donors with primary central nervous system tumor, Transplantation, 2000, 70, pp. 244-248
DETRY O. , HONORE P, DELWAIDE J, et al. Liver transplantation in a Jehovah's witness, Lancet, 1999, 353, pp. 1680

Dr. J. Henrion
HENRION J , SCHAPIRA M, COLIN L, et al Hypoxic hepatitis:clinical and hemodynamic study in 142 cases, A prospective study, Medicine, 2003, 82, pp. 392-406
HENRION J , MINETTE PH, COLIN L, et al Hypoxic hepatitis due to exacerbation ofchronic respiratory failure, A case controlled hemodynamic study of 17 consecutive cases, Hepatology, 1999, 29, pp. 427-433
HENRION J , DESCAMPS O, LUWAERT R, et al Hypoxic hepatitis in patients with cardiac failure, Incidence in a coronary care unit and measurement of hepatic blood flow, J, Hepatol, 1994, 21, pp. 696-703
HENRION J , HAUTEKEETE M, BRENARD R, et al Insuffisance hépatocellulaire fulminante et subfulminante secondaire à une infiltration métastatique du foie: une autre cause d'hépatite hypoxique, Gastroenterol. Clin. Biol., 1996, 20, pp. 535-543
HENRION J , LIBON E, DE MAEGHT S, et al Dépistage du carcinome hépatocellulaire dans une cohorte de malades porteurs d'une cirrhose d'origine principalement alccoolique, Gastroenterol. Clin. Biol., 2003, 27, pp. 534-539
HENRION J , Hypoxic hepatitis: The point of view of the clinician, Acta Gastroenterol, Belg,, 2006, 69, pp. 214-216

Pr. E. Louis
LOUIS E , BOVERIE J, DEWIT O, et al. Treatment of small bowel subocclusive Crohn’s disease with infliximab: an open pilot study, Acta Gastroenterol Belg, 2007, 70, pp. 15--19
LOUIS E , ANCION G, COLARD A, et al. Non invasive assessment of Crohn’s disease intestinal lesions with 18FDG PET/CT, J Nucl Med, 2007, 48, pp. 1--7
DENIS M , REENAERS C, FONTAINE F, et al. Assessment of endoscopic activity index and biological ionflammatory markers in clinical active Crohn’s disease with normal C-reactive protein serum level, Inflamm Bowel Dis, 2007, 9, pp. 1100--1105
MEUWIS M , FILLET M, GEURTS P, et al. Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling, Biochemical Pharmacology, 2007, 73, pp. 1422--1433
URBAIN A , TRESINIE M, DE LOOZE D, et al. Capsule endoscopy in paediatrics : multicentric Belgian Study, Acta Gastroenterol Belg, 2007, 70, pp. 11--14
VAN GOSSUM A , DEWIT O, LOUIS E, et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection, Inflamm Bowel Dis, 2007, 13, pp. 135--142
DE JAGER P , FRANCHIMONT D, WALISZEWSKA A, et al. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases, Genes Immun, 2007, 8, pp. 387-397
LIBIOULLE C , LOUIS E, HANSOUL S, et al. A novel susceptibility locus for Crohn’s disease identified by whole genome association maps to a gene desert on chromosome 5p13.1 and modulates the level of expression of the prostaglandin receptor EP4, Plos Genetics, 2007, 3, pp. 538--543
BAERT F , DE VOS M, LOUIS E, et al. Immunogenicity of infliximab: how to handle the problem?, Acta Gastroenterol Belg, 2007, 70, pp. 163--170
DIDEBERG V , KRISTJANDOTTIR G, MILANI L, et al. An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases, Hum Mol Genet, 2007, , pp.
SATSANGI J , PARKES M, LOUIS E, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for suceptibility loci on chromosomes 3, 7 and 12, Nature Genetics, 1996, 14, pp. 199--202
LOUIS E , COLARD A, OGER A, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease, Gut, 2001, 49, pp. 777--782
VERMEIRE S , LOUIS E, RUTGEERTS P, et al. NOD2/CARD15 does not influence response to infliximab in Crohn's disease, Gastroenterology, 2002, 123, pp. 106--111
LOUIS E , ANCION G, COLARD A, et al. Non invasive assessment of Crohn’s disease intestinal lesions with 18FDG PET/CT, J Nucl Med, 2007, 48, pp. 1--7
LIBIOULLE C , LOUIS E, HANSOUL S, et al. A novel susceptibility locus for Crohn’s disease identified by whole genome association maps to a gene desert on chromosome 5p13.1 and modulates the level of expression of the prostaglandin receptor EP4, Plos Genetics, 2007, 3, pp. 538--543

Pr. P. Michielsen
MICHIELSEN P.P. , BOECKXSTAENS G.E., SYS S.U., et al. Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats, Eur J Pharmacol, 1995, 273, pp. 167-174
MICHIELSEN P.P. , BOECKXSTAENS G.E., SYS S.U., et al. The role of increased nitric oxide oin the vascular hyporeactivity to noradrenaline in long-term portal hypertensive rats., J Hepatol, 1995, 23, pp. 341-347
MICHIELSEN P.P. , BOECKXSTAENS G.E., SYS S.U., et al. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein ligated rats, Eur J Pharmacol, 1997, 329, pp. 137-146
MICHIELSEN P.P. , FRANCQUE S.M., VAN DONGEN J.L., Viral hepatitis and hepatocellular carcinoma., World J Surg Oncol, 2005, 3, pp. 27
ROBAEYS G. , BUNTINX F., BOTTIEAU E., et al. Guidelines for the management of chronic hepatitis C in patients infected after drug use, Acta Gastroenterol Belg, 2005, 68, pp. 38-45
SCHOUTEN J. , MICHIELSEN P., , Treatment of cirrhotic ascites., Acta Gastroenterologica Belgica, 2007, 70, pp. 217-222
DE PAUW F.F. , FRANCQUE S.M., BOGERS J.J., et al. Fine needle trucut biopsy in focal liver lesions: a reliable and safe method in identifying the malignant nature of liver lesions, Acta Gastroenterologica Belgica, 2007, 70, pp. 1_7
BUSTER H.C.J. , HANSEN B.E., BUTI M., et al. Peginterferon alpha-2b is safe and effective in HBeAg positive chronic hepatitis B patents with advanced fibrosis, Hepatology, 2007, 46, pp. 388-394
ROBAEYS G. , DE BIE J., WICHERS M.C., et al. Early prediction of major depression in chronic hepatitis C patients during peg-interferon α-2b treatment by assessment of vegatativedepressive symptoms after four weeks., World J Gastroenterol, 2007, 13, pp. 5736-5740
COLLE I. , ADLER M., BRENARD R., et al. Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines., Acta Gastroenterologica Belgica, 2007, 70, pp. 389-420

Dr. M. Schapira
SCHAPIRA M. , ADLER M., , Colonoscopy as a screening test for colorectal cancer, acta gastroenterol belg, 2005, 68, pp. 251-256
SCHAPIRA M. , MAISIN JM., GHILAIN JM., et al. Epidemiology of coeliac disease, acta gastroenterol belg, 2003, 66, pp. 234-236
SCHAPIRA M. , HENRION J., RAVOET C., et al. Thromboembolism in inflammatory bowel, acta gastroenterol belg, 1999, 62, pp. 182-186
SCHAPIRA M. , ROQUET ME., HENRION J., et al. Severe nontyphoidal salmonellosis probably in relation with omeprazole treatment, acta gastroenterol belg, 1996, 59, pp. 168-169
SCHAPIRA M. , NICKERS PH., HENRION J., et al. Endoscopic ultrasonography as an aid to non surgical nor endoscopic treatment of tumors, acta endoscopica, 1994, 24, pp. 03 --10